We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

101 hedge funds and large institutions have $318M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

4% less funds holding

Funds holding: 105 → 101 (-4)

9% less capital invested

Capital invested by funds: $351M → $318M (-$32.3M)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
101
Holders Change
-4
Holders Change %
-3.81%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
36
Reduced
27
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.48M
2
CM
Crestline Management
Texas
+$3M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.9M
4
Marshall Wace
Marshall Wace
United Kingdom
+$2.55M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
SGA
Strategic Global Advisors
California
-$6.27M
2
AL
AJO LP
Pennsylvania
-$4.2M
3
Norges Bank
Norges Bank
Norway
-$1.93M
4
Morgan Stanley
Morgan Stanley
New York
-$1.53M
5
HSBC Holdings
HSBC Holdings
United Kingdom
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$54.4M +$1.14M +14,059 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$43.9M +$2.33M +28,736 +5%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$29.3M +$2.9M +35,700 +10%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$24.9M -$271K -3,345 -1%
Norges Bank
5
Norges Bank
Norway
$15.2M -$1.93M -23,763 -11%
APG Asset Management
6
APG Asset Management
Netherlands
$14.3M -$341K -4,200 -2%
Invesco
7
Invesco
Georgia
$10.7M +$968K +11,921 +9%
Arrowstreet Capital
8
Arrowstreet Capital
Massachusetts
$10.4M -$1.13M -13,980 -9%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$6.53M +$538K +6,623 +8%
CAM
10
Claret Asset Management
Quebec, Canada
$6.52M -$490K -6,041 -7%
Schroder Investment Management Group
11
Schroder Investment Management Group
United Kingdom
$6.46M +$1.5M +18,500 +28%
Millennium Management
12
Millennium Management
New York
$6.22M +$4.48M +55,150 +202%
Citadel Advisors
13
Citadel Advisors
Florida
$5.52M +$2.25M +27,733 +61%
BIP
14
Brandes Investment Partners
California
$5.47M -$68.2K -840 -2%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$5.06M +$2.45M +30,132 +82%
Hotchkis & Wiley Capital Management
16
Hotchkis & Wiley Capital Management
California
$5.05M +$248K +3,050 +5%
Northern Trust
17
Northern Trust
Illinois
$4.37M +$379K +4,673 +9%
Robeco Institutional Asset Management
18
Robeco Institutional Asset Management
Netherlands
$4.03M – – –
PPA
19
Parametric Portfolio Associates
Washington
$3.66M +$1.01M +12,505 +35%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$3.66M -$118K -1,459 -3%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$3.14M +$458K +5,642 +16%
OAC
22
OMERS Administration Corp
Ontario, Canada
$3M +$739K +9,100 +30%
Marshall Wace
23
Marshall Wace
United Kingdom
$2.98M +$2.55M +31,418 +392%
Charles Schwab
24
Charles Schwab
California
$2.81M +$267K +3,290 +10%
CM
25
Crestline Management
Texas
$2.79M +$3M +37,000 New
1
2 3 4 5

TARO Hedge Fund Activity: Q3 2019 in Review

101 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2019, worth a combined $318M — down 9.2% from $351M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TARO and 12 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 36 added.

The largest buyer was Millennium Management, adding an estimated $4.48M. The largest seller was Strategic Global Advisors, exiting entirely with an estimated $6.27M sold.

  • 101 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2019, down from 105 in Q2 2019.
  • Funds reported $318M of Taro Pharmaceutical Industries Ltd. stock for Q3 2019, down 9.2% quarter-over-quarter.
  • 12 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2019 and 14 closed out, a net change of -2 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2019 was Millennium Management, an estimated $4.48M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2019 was Strategic Global Advisors, an estimated $6.27M sold.

Based on aggregated 13F filings for Q3 2019.